Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

American Journal of Epidemiology

Volumn 172, Issue 1, 2010, Pages 58-69

  Purdue, Mark P ^a   Freedman, D Michal ^a   Gapstur, Susan M ^a   Helzlsouer, Kathy J ^a   Laden, Francine ^a   Lim, Unhee ^a   Maskarinec, Gertraud ^a   Rothman, Nathaniel ^a   Shu, Xiao Ou ^a   Stevens, Victoria L ^a   Zeleniuch Jacquotte, Anne ^a   Albanes, Demetrius ^a   Bertrand, Kimberly ^a   Weinstein, Stephanie J ^a   Yu, Kai ^a   Irish, Lonn ^a   Horst, Ronald L ^a   Hoffman Bolton, Judith ^a   Giovannucci, Edward L ^a   Kolonel, Laurence N ^a   Snyder, Kirk ^a   Willett, Walter ^a   Arslan, Alan A ^a   Hayes, Richard B ^a   Zheng, Wei ^a   Xiang, Yong Bing ^a   Hartge, Patricia ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

25 hydroxyvitamin D 2; Calcifediol; Calcitrol; Case control studies; Cohort studies; Lymphoma; Non Hodgkin; Prospective studies; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

BLOOD SYSTEM DISORDER; CANCER; COHORT ANALYSIS; CONTROL SYSTEM; HEALTH RISK; IMMUNOASSAY; LOGISTICS; PUBLIC HEALTH; VITAMIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HISTOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMAGENESIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ONCOGENESIS AND MALIGNANT TRANSFORMATION; RISK ASSESSMENT; SEASON; SUN EXPOSURE; BLOOD; CHINA; COHORT ANALYSIS; FINLAND; META ANALYSIS (TOPIC); MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SUNLIGHT; UNITED STATES; VITAMIN D DEFICIENCY;

ADULT; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; FEMALE; FINLAND; HUMANS; LOGISTIC MODELS; LYMPHOMA, NON-HODGKIN; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEASONS; SUNLIGHT; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78549256932     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq117     Document Type: Article

References (36)

1. Armstrong BK, Kricker A. Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3): 396-400.
2. Hartge P, Devesa SS, Grauman D, et al. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst. 1996;88(5):298-300.
3. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ. 1997;314(7092):1451-1455.
4. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164: 371-377.
5. Hu S, Ma F, Collado-Mesa F, et al. Ultraviolet radiation and incidence of non-Hodgkin's lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev. 2004; 13(1):59-64.
6. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer. 1996;73(7):945-950.
7. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ. 1996;312(7039):1128-1131.
8. Langford IH, Bentham G, McDonald AL. Mortality from non-Hodgkin lymphoma and UV exposure in the European Community. Health Place. 1998;4(4):355-364.
9. Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004;112(5):865-871.
10. Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97(3):199-209.
11. Hartge P, Lim U, Freedman DM, et al. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2006;17(8): 1045-1052.
12. Weihkopf T, Becker N, Nieters A, et al. Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer. 2007;120(11):2445-2451.
13. Petridou ET, Dikalioti SK, Skalkidou A, et al. Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece. Cancer Causes Control. 2007;18(9):1031-1037.
14. Soni LK, Hou L, Gapstur SM, et al. Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. Eur J Cancer. 2007;43(16):2388-2395.
15. Zhang Y, Holford TR, Leaderer B, et al. Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol. 2007;165(11):1255-1264.
16. Kricker A, Armstrong BK, Hughes AM, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008; 122(1):144-154.
17. Kricker A, Armstrong B. Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol. 2006; 92(1):132-139.
18. Bhalla AK, Amento EP, Clemens TL, et al. Specific highaffinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57(6):1308-1310.
19. Provvedini DM, Tsoukas CD, Deftos LJ, et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181-1183.
20. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634-1647.
21. Hickish T, Cunningham D, Colston K, et al. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer. 1993;68(4): 668-672.
22. Raina V, Cunningham D, Gilchrist N, et al. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer. 1991;63(3):463-465.
23. Lim U, Freedman DM, Hollis BW, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009;124(4):979-986.
24. Gallicchio L, Helzlsouer KJ, Chow WH, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):10-20.
25. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009;42(15):1549-1556.
26. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002; 30(5):771-777.
27. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-281.
28. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2): 73-78.
29. Viechtbauer W. MiMa: an S-Plus/R function to fit meta-analytic mixed-, random-, and fixed-effects models [computer software and manual]. 2006 (http://www.wvbauer.com/downloads.html). (Accessed February 6, 2009).
30. McCullough ML, Weinstein SJ, Freedman DM, et al. Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):21-35.
31. Purdue MP, Hartge P, Davis S, et al. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2007;18(9):989-999.
32. Platz EA, Leitzmann MF, Hollis BW, et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004;15(3): 255-265.
33. Ullrich SE. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol. 1996;64(2):254-258.
34. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 1999;140(6):995-1009.
35. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol. 2001;79(6):547-568.
36. Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst. 2005;97(8):587-594.